GFAP is an activation marker for astrocyte glial cells and the results indicate the presence of astrocyte activating factors in the central nervous system of MS suffering patients, which could be a survival and repair signal, as a response of central nervous system components of the disease. This evidence concerns the gene GFAP and myeloid sarcoma.